๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Colorimetric response to ehrlich's reagent in plasma from patients with and without cancer

โœ Scribed by Daniel W. Nixon


Publisher
John Wiley and Sons
Year
1973
Tongue
English
Weight
316 KB
Volume
31
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Serological immune response to cancer te
โœ Andreas Wadle; Boris Kubuschok; Jochen Imig; Beate Wuellner; Christine Wittig; C ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 380 KB

## Abstract Serological screening approaches have allowed for the identification of a large number of potentially relevant tumor antigens in cancer patients. Within this group, cancer testis antigens represent promising targets for cancer immunotherapy, since they are widely expressed in a variety

Endogenous immune response to gangliosid
โœ Mepur H. Ravindranath; Sakunthala Muthugounder; Naftali Presser; Xing Ye; Stanle ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 584 KB

## Abstract Our study investigated whether endogenous IgM antibodies to gangliosides occur in patients with early stages of prostate cancer (CaP) patients, after defining ganglioside profiles of CaP cell lines. Immune and resorcinol staining detected the presence of gangliosides GM3, GM2, GD3, GD2

Response of plasma fibrinogen and plasmi
โœ U. S. Seal; R. P. Doe; D. P. Byar; D. K. Corle ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 869 KB

Fibrinogen and plasminogen were measured in plasma samples from prostatic cancer patients before and after 3 months of treatment with either Premarin, Provera, Provera and diethylstilbestrol, one of three doses of diethylstilbestrol, o r placebo. Plasminogen levels generally were increased significa

Antibodies to GM1 and GD1b in patients w
โœ Dr. Michael E. Shy; Vance A. Evans; Fred D. Lublin; Robert L. Knobler; Terry Hei ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 464 KB ๐Ÿ‘ 2 views

Fifty-nine percent of 49 patients with motor neuron disease and 25% of 91 control subjects had IgM antibodies to ganglioside GM1 but usually not to GDlb at titers less than 1:80. This suggests that antibodies to GM1 may be part of the normal human antibody repertoire. However, given the higher incid